For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $149.93 in the prior trading day, Keysight Technologies Inc (NYSE: KEYS) closed at $146.89, down -2.03%. In other words, the price has decreased by -$2.03 from its previous closing price. On the day, 1.05 million shares were traded. KEYS stock price reached its highest trading level at $149.87 during the session, while it also had its lowest trading level at $146.655.
Ratios:
Our goal is to gain a better understanding of KEYS by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.67 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 21.60. For the most recent quarter (mrq), Quick Ratio is recorded 1.34 and its Current Ratio is at 1.93. In the meantime, Its Debt-to-Equity ratio is 0.43 whereas as Long-Term Debt/Eq ratio is at 0.29.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on February 15, 2024, Downgraded its rating to Neutral and sets its target price to $170 from $184 previously.
On September 15, 2023, Morgan Stanley Upgraded its rating to Overweight which previously was Equal-Weight but kept the price unchanged to $165.
Goldman Upgraded its Neutral to Buy on September 05, 2023, whereas the target price for the stock was revised from $146 to $164.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 26 ’24 when NARAYANAN KAILASH sold 4,300 shares for $152.88 per share. The transaction valued at 657,384 led to the insider holds 29,156 shares of the business.
Nersesian Ronald S. sold 29,672 shares of KEYS for $4,742,179 on Dec 27 ’23. The Director now owns 296,619 shares after completing the transaction at $159.82 per share. On Dec 15 ’23, another insider, Dougherty Neil, who serves as the EVP and CFO of the company, sold 14,686 shares for $159.35 each. As a result, the insider received 2,340,214 and left with 106,793 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KEYS now has a Market Capitalization of 25640529920 and an Enterprise Value of 25953507328. As of this moment, Keysight’s Price-to-Earnings (P/E) ratio for their current fiscal year is 26.98, and their Forward P/E ratio for the next fiscal year is 20.16. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 6.22. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.80 while its Price-to-Book (P/B) ratio in mrq is 5.33. Its current Enterprise Value per Revenue stands at 4.858 whereas that against EBITDA is 17.268.
Stock Price History:
Over the past 52 weeks, KEYS has reached a high of $172.72, while it has fallen to a 52-week low of $118.57. The 50-Day Moving Average of the stock is -4.85%, while the 200-Day Moving Average is calculated to be 0.30%.
Shares Statistics:
The stock has traded on average 1.29M shares per day over the past 3-months and 1325520 shares per day over the last 10 days, according to various share statistics. A total of 174.60M shares are outstanding, with a floating share count of 173.12M. Insiders hold about 0.82% of the company’s shares, while institutions hold 87.39% stake in the company. Shares short for KEYS as of 1711584000 were 3431225 with a Short Ratio of 2.67, compared to 1709164800 on 3063966. Therefore, it implies a Short% of Shares Outstanding of 3431225 and a Short% of Float of 2.55.
Earnings Estimates
The company has KeyCorp analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $146.89, with high estimates of $163.97 and low estimates of $28.39.
Analysts are recommending an EPS of between $Healthcare and $Consumer Cyclical for the fiscal current year, implying an average EPS of $Technology.
